Home
About
About Anagenics
Board of Directors
Divisions
Our Divisions
Beauty
Brands
évolis®
Uspa
Investors
Investor Centre
ASX Announcements
2024
2023
2022
2021
2020
2019
Financial Information & Reports
Share Registry Information
Analyst Coverage
Share Information
Anagenics in the media
Newsletter Archive
Corporate Governance
Corporate Governance
Board Charter
Code of Conduct
Policies
Audit Committee Charter
Nomination and Remuneration Committee Charter
Performance Evaluation Process
Corporate Code of Conduct
Environmental, Social and Governance Statement
✕
2020
Home
2020
June 18, 2020
Published by
Tiffany McMillan
on
June 18, 2020
Categories
Appendix 3Y – Change of Director’s Interest Notice
June 18, 2020
Published by
Tiffany McMillan
on
June 18, 2020
Categories
Appendix 3Y – Change of Director’s Interest Notice
June 18, 2020
Published by
Tiffany McMillan
on
June 18, 2020
Categories
Appendix 3G – Notification of issue, conversion or payment up of equity +securities
June 18, 2020
Published by
Tiffany McMillan
on
June 18, 2020
Categories
Appendix 2A – Application for quotation of +securities
June 16, 2020
Published by
Tiffany McMillan
on
June 16, 2020
Categories
Cellmid reports on strong QVC sales event
June 15, 2020
Published by
Tiffany McMillan
on
June 15, 2020
Categories
Cellmid reports on results of the Doherty Institute testing
June 4, 2020
Published by
Tiffany McMillan
on
June 4, 2020
Categories
Cellmid signs introducer agreement to broaden product offering
June 1, 2020
Published by
Tiffany McMillan
on
June 1, 2020
Categories
Cellmid appoints Dr Dominic Burg as Chief Operating Officer
May 22, 2020
Published by
Tiffany McMillan
on
May 22, 2020
Categories
Results of May 2020 General Meeting
Prev page
1
2
3
4
5
6
7
8
9
Next page
